KR

Healthcare · Healthcare Service Provider

Krsnaa Diagnostics Ltd (KRSNAA)

₹519.05

Mkt cap
₹1,684 Cr
P/E ratio
16.70
P/B
1.60
Div yield
0.39%
ROE
10.90%
ROCE
12.70%
EPS (TTM)
₹31.08
Book value
₹324
52W range
463–838
Sector
Healthcare

Price history

Previous close

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. [1]

NSE KRSNAABSE 543328
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthHigh
TechnicalsBearish
52-week range
−38.06% from high
₹519
₹463+12.08% from low₹838
Current
₹519.05
Prev close
₹515.65
Day
+0.66%
Price performance
1D
+0.80%
1W
−1.69%
1M
+0.80%
3M
−5.49%
6M
−7.49%
1Y
−35.52%
YTD
−29.22%

Financials

Revenue, profit & margin
P/E ratio
16.7×
KRSNAA is 52% below the sector median of 35.0×
KRSNAA16.7×
Sector median35.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales147152159163179165175176183159173211240
YoY Sales growth+22%+31%+38%+23%+22%+9%+10%+8%+2%-3%-1%+20%+31%
Expenses116113116120126117121126125112116154168
Operating Profit31384343524853505848575772
OPM %21%25%27%26%29%29%31%29%32%30%33%27%30%
Other Income44475944443176
Interest3475667688121515
Depreciation18211821222322222323222829
Profit before tax14172224282829263121542234
Tax %20%20%17%23%23%24%28%26%24%22%20%26%25%
Net Profit11141818222221202316431625
EPS in Rs3.604.215.705.636.806.696.536.037.165.0813.374.887.81
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.16% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast14 Aug '262 Nov '26
Earnings day+3.33%−1.00%
+1 day+0.31%−3.56%
+5 days+0.88%−2.01%
+15 days+0.58%—
+30 days−4.08%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
27.11%Promoter
Promoters27.11%
FIIs3.84%0.44
DIIs14.50%
Public54.55%0.47
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹2,006.0055.6133,6700.70%194+28.75%874+19.61%28.00%
Vijaya Diagnost.₹1,572.3079.5116,1940.13%59+37.41%255+26.71%20.53%
Metropolis Healt₹566.0050.8911,7460.35%75+43.04%497+15.76%17.81%
Thyrocare Tech.₹528.4548.078,4211.77%15−11.56%271+25.07%35.38%
Nephrocare Health Services₹655.8051.656,6170.00%34+454.07%303+23.47%15.34%
Krsnaa Diagnost.₹519.0516.671,6840.39%25+8.95%240+31.17%12.71%
Suraksha Diagno.₹311.5038.791,6220.16%15+66.96%99+25.84%17.29%
Median: 16 Co.₹342.2735.039980.07%15+10.52%83+24.27%21.66%

Filings